Skip to main content
SpringerLink
Log in

NICE OKs arthritis therapies, not pemetrexed for NSCLC

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. National Institute for Health and Clinical Excellence.NICE appraisal of rituximab and adalimumab for the treatment of arthritis. Media Release: 22 Aug 2007. Available from: URL: http://www.nice.org.uk

  2. National Institute for Health and Clinical Excellence.NICE issues guidance on pemetrexed (Alimta) for the treatment of non-small-cell lung cancer. Media Release: 22 Aug 2007. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

NICE OKs arthritis therapies, not pemetrexed for NSCLC. Pharmacoecon. Outcomes News 536, 3 (2007). https://doi.org/10.2165/00151234-200705360-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705360-00005

Keywords

Search

Navigation